Abstract
Pregnant mice were given p.o. various nonteratogenic doses (0, 2.5, 5 and 10 mg/kg) of methylmercuric chloride on day 9 of pregnancy, and then injected i. p. with a teratogenic dose (4 mg/kg) of mitomycin-C on day 10. Major malformations produced by mitomycin-C alone were cervical rib and vertebral anomaly, polydactyly of the hindlimb and tail anomaly. Combined treatment significantly increased the incidence of these malformations, showing the dose-effect relationship of methylmercury, whereas methylmercury alone is known not to produce such malformations. When mitomycin-C treatment alone was performed on day 9.5 of pregnancy, only vertebral anomalies increased in incidence. Therefore, mitomycin-C teratogenicity in terms of the manifestation of cervical rib, polydactyly and tail anomaly, but not vertebral anomaly, was suggested to be enhanced by methylmercury. A considerable number of foetuses showed cleft palate involvement following combined treatments, but not by either chemical alone. Cleft palate is known to be a major malformation in mice that is caused by methylmercury, and mitomycin-C also induces cleft palate. Therefore, the two chemicals might have affected foetuses additively and thereby induced cleft palate.
Similar content being viewed by others
References
Chang LW, Desnoyers PA (1978) Methylmercury induced biochemical and microsomal changes in the rat liver. J Environ Pathol Toxicol 1: 569–579
Connors TA (1975) Cytotoxic agents in teratogenic research. In: Berry CL, Poswillo DE (ed) Teratology — trends and application. Springer, Berlin Heidelberg New York, pp 49–79
Fujii T, Nakatsuka T (1983) Potentiating effects of caffeine on teratogenicity of alkylating agents in mice. Teratology 28: 29–33
Fuyuta M, Fujimoto T, Kiyofuji E (1979) Teratogenic effects of a single oral administration of methylmercuric chloride in mice. Acta Anat 104: 356–362
Inouye M (1976) Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red S. Cong Anom 16: 171–173
Inouye M, Murakami U (1975) Teratogenic effect of orally administered methylmercuric chloride in rats and mice. Cong Anom 15: 1–9
Inouye M, Kajiwara Y, Hirayama K (1986) Dose- and sex-dependent alterations in mercury distribution in fetal mice following methylmercury exposure. J Toxicol Environ Health 19: 425–437
Lu FC (1974) Mercury as a food contaminant. WHO Chronicle 28: 8–11
Miura K, Suzuki K, Imura N (1978) Effects of methylmercury on mitotic mouse glioma cells. Environ Res 17: 453–471
Roberts JJ, Sturrock JE, Ward KN (1974) The enhancement by caffeine of alkylation-induced cell death, mutations and chromosomal aberrations in Chinese hamster cells, as a result of inhibition of post-replication DNA repair. Mutat Res 26: 129–143
Sarafian T, Verity MA (1986) Mechanism of apparent transcription inhibition by methyl mercury in cerebellar neurons. J Neurochem 47: 625–631
Slotkin TA, Pachman S, Kavlock RJ, Bartlome J (1985) Effects of neonatal methylmercury exposure on development of nucleic acids and proteins in rat brain: Regional specificity. Brain Res Bull 14: 397–400
Spyker JM, Smithberg M (1972) Effects of methylmercury on prenatal development in mice. Teratology 5: 181–190
Su M, Okita GT (1976) Embryocidal and teratogenic effects of methylmercury in mice. Toxicol Appl Pharmacol 38: 207–216
Tanimura T (1968) Effects of mitomycin C administered at various stages of pregnancy upon mouse fetuses. Okajimas Folia Anat Jpn 44: 337–355
Vallee BL, Ulmer DD (1972) Biochemical effects of mercury, cadmium, and lead. Annu Rev Biochem 41: 91–128
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inouye, M., Kajiwara, Y. Teratogenic interactions between methylmercury and mitomycin-C in mice. Arch Toxicol 61, 192–195 (1988). https://doi.org/10.1007/BF00316633
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00316633